Pre-clearance

Canada ／ Health Canada / PAAB

Preclearance of advertising for marketed health products is administered through an independent, self-regulatory and voluntary system, with PAAB reviewing material directed to health professionals and Advertising Standards Canada and MIJO reviewing non-prescription drug and natural health product material directed to consumers.

市販後の医薬品広告の事前審査は独立・自主規制・任意の制度として運営され、医療従事者向けはPAAB、消費者向けの一般用医薬品および天然健康製品はAdvertising Standards CanadaおよびMIJOが審査する。

regulator guidanceGuidance Document - Health Canada and Advertising Preclearance Agencies' Roles Related to Health Product Advertisingchecked 2026-09-23

Note
The page as fetched contains no exception making preclearance mandatory for any product class; a claim seen in secondary sources that preclearance is mandatory for opioids was NOT confirmed on this page and is therefore not stated here.

The same topic elsewhere

Japan ── Sales information materials must be reviewed before use by an in-house promoti…United States ── An applicant must submit specimens of promotional labeling and advertising at …European Union ── Member States must ensure that there are adequate and effective methods to mon…United Kingdom ── The MHRA has statutory powers to require companies to submit advertising mater…China ── Advertisements for medical services, drugs and medical devices must be reviewe…Australia ── Use of a restricted representation, that is one referring to a serious form of…Korea ── A manufacturer, marketing authorisation holder or importer that intends to adv…Switzerland ── Switzerland has no across-the-board pre-vetting scheme: prior authorisation by…